Nuzenio

Tradingview Lgnd

Tradingview Lgnd entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 16 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Legend Biotech Corporation expected to post earnings of 7 cents a share - Earnings Preview - TradingViewTradingView · Fri, 07 Aug 2026 17:24:06 GMTLigand Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 21:03:55 GMTLigand Pharmaceuticals Incorporated Stock 12‑Month Price Target Raised to $343.3, Implies 13% Upside - TradingViewTradingView · Thu, 06 Aug 2026 20:23:23 GMTMacau Legend Development Limited Revenue Breakdown – HKEX:1680 - TradingViewTradingView · Thu, 06 Aug 2026 18:25:56 GMTLGND: Q2 2026 delivered record royalty growth, XOMA integration, and robust guidance for continued expansion - TradingViewTradingView · Thu, 06 Aug 2026 15:56:41 GMTLGND: Q2 2026 delivered strong revenue and EPS growth, fueled by the XOMA acquisition and robust royalty gains - TradingViewTradingView · Thu, 06 Aug 2026 14:48:23 GMTGENI: Revenue and EBITDA exceeded guidance, with Legend synergies accelerating growth - TradingViewTradingView · Thu, 06 Aug 2026 14:05:15 GMTLGND: Q2 2026 royalty revenue up 32%, adjusted EPS guidance raised after XOMA acquisition and debt financing - TradingViewTradingView · Thu, 06 Aug 2026 12:28:27 GMT

Timeline

Fri, 07 Aug 2026 17:24:06 GMTLegend Biotech Corporation expected to post earnings of 7 cents a share - Earnings Preview - TradingView
Thu, 06 Aug 2026 21:03:55 GMTLigand Pharmaceuticals Q2 Earnings Call Highlights - TradingView
Thu, 06 Aug 2026 20:23:23 GMTLigand Pharmaceuticals Incorporated Stock 12‑Month Price Target Raised to $343.3, Implies 13% Upside - TradingView
Thu, 06 Aug 2026 18:25:56 GMTMacau Legend Development Limited Revenue Breakdown – HKEX:1680 - TradingView
Thu, 06 Aug 2026 15:56:41 GMTLGND: Q2 2026 delivered record royalty growth, XOMA integration, and robust guidance for continued expansion - TradingView
Thu, 06 Aug 2026 14:48:23 GMTLGND: Q2 2026 delivered strong revenue and EPS growth, fueled by the XOMA acquisition and robust royalty gains - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Lgnd.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.